(2019). IP-Based Incentives Against Antimicrobial Crisis: A European Perspective IIC - international review of intellectual property and competition law, 50 (1), 30-76.
The field of antimicrobials is considered to be facing a crisis. Increasing
microbial resistance is creating a demand for new drugs, which however is not being
matched by privately funded R&D. The reasons for this market failure are of a
technical and economic nature. The present article analyzes what changes to IP-
based incentives are conceivable in the European Union (EU) in order to address the
antimicrobial crisis. Since the assessment of the suitability of the analyzed options
depends on interdisciplinary research, this article also proposes a research agenda to
be considered for the implementation of public policies in this field.
